Daniela Süßkind

1.2k total citations
39 papers, 784 citations indexed

About

Daniela Süßkind is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniela Süßkind has authored 39 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Ophthalmology, 10 papers in Molecular Biology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniela Süßkind's work include Ocular Oncology and Treatments (22 papers), Corneal Surgery and Treatments (6 papers) and Immunotherapy and Immune Responses (6 papers). Daniela Süßkind is often cited by papers focused on Ocular Oncology and Treatments (22 papers), Corneal Surgery and Treatments (6 papers) and Immunotherapy and Immune Responses (6 papers). Daniela Süßkind collaborates with scholars based in Germany, United Kingdom and United States. Daniela Süßkind's co-authors include Henrike Westekemper, Karl Ulrich Bartz‐Schmidt, Klaus Griewank, Bastian Schilling, Dirk Schadendorf, Rajmohan Murali, Antje Sucker, Florian Grabellus, Peter Szurman and Uwe Hillen and has published in prestigious journals such as Blood, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Daniela Süßkind

37 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Süßkind Germany 13 432 387 196 195 177 39 784
Zerrin Onadim United Kingdom 15 615 1.4× 490 1.3× 83 0.4× 382 2.0× 41 0.2× 33 897
S Khorana United States 11 250 0.6× 241 0.6× 69 0.4× 184 0.9× 62 0.4× 12 639
Barbro Werelius Sweden 15 140 0.3× 519 1.3× 48 0.2× 444 2.3× 514 2.9× 23 1.1k
Jennifer Richards‐Yutz United States 10 287 0.7× 169 0.4× 87 0.4× 203 1.0× 17 0.1× 12 496
Jerry A. Shields United States 15 489 1.1× 276 0.7× 21 0.1× 232 1.2× 60 0.3× 23 743
Irsan Kooi Netherlands 12 230 0.5× 231 0.6× 48 0.2× 185 0.9× 19 0.1× 15 483
Adriana C. H. van Engen–van Grunsven Netherlands 15 73 0.2× 342 0.9× 40 0.2× 158 0.8× 82 0.5× 37 636
Teemu Mäkitie Finland 9 420 1.0× 179 0.5× 181 0.9× 285 1.5× 15 0.1× 12 674
Amaury G. Dumont United States 6 235 0.5× 133 0.3× 129 0.7× 323 1.7× 43 0.2× 6 545
Trinh Pham United States 7 151 0.3× 307 0.8× 234 1.2× 132 0.7× 71 0.4× 11 528

Countries citing papers authored by Daniela Süßkind

Since Specialization
Citations

This map shows the geographic impact of Daniela Süßkind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Süßkind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Süßkind more than expected).

Fields of papers citing papers by Daniela Süßkind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Süßkind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Süßkind. The network helps show where Daniela Süßkind may publish in the future.

Co-authorship network of co-authors of Daniela Süßkind

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Süßkind. A scholar is included among the top collaborators of Daniela Süßkind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Süßkind. Daniela Süßkind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seitz, Immanuel P., G. Alex Ochakovski, Felix F. Reichel, et al.. (2025). Ocular Safety and Toxicology of Subretinal Gene Therapy With rAAV.hPDE6A in Nonhuman Primates. Translational Vision Science & Technology. 14(1). 29–29. 1 indexed citations
2.
Seitz, Christian, Ines B. Brecht, Martin Ebinger, et al.. (2024). Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3. Cancer Immunology Immunotherapy. 73(1). 19–19. 4 indexed citations
3.
Schroeder, Christopher, Tobias Sinnberg, Irina Bonzheim, et al.. (2023). Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case report. Frontiers in Oncology. 13. 1167791–1167791. 4 indexed citations
4.
Bonzheim, Irina, Julia Salmerón‐Villalobos, Daniela Süßkind, et al.. (2023). Molekulare Diagnostik des vitreoretinalen Lymphoms. PubMed. 44(S3). 150–154.
5.
Süßkind, Daniela, et al.. (2021). Exploring the role of BAFF as biomarker in the detection of uveal melanoma metastases. Journal of Cancer Research and Clinical Oncology. 147(5). 1389–1405. 4 indexed citations
6.
7.
Walz, Johanna M., Daniela Süßkind, Lars Wagenfeld, et al.. (2018). Behandelte Frühgeborenenretinopathie in Deutschland. Der Ophthalmologe. 115(6). 476–488. 13 indexed citations
8.
Scholz, Simone L., Inga Möller, Henning Reis, et al.. (2017). Frequent GNAQ, GNA11 , and EIF1AX Mutations in Iris Melanoma. Investigative Ophthalmology & Visual Science. 58(9). 3464–3464. 26 indexed citations
9.
Süßkind, Daniela, W. Inhoffen, Faik Gelişken, & Michael Völker. (2017). Photodynamic therapy with double duration for circumscribed choroidal haemangioma: functional and anatomical results based on initial parameters. Clinical and Experimental Ophthalmology. 46(5). 495–501. 11 indexed citations
10.
Doycheva, Deshka, et al.. (2015). Diagnostik und Therapie der choroidalen Lymphome. Der Ophthalmologe. 112(3). 217–222. 7 indexed citations
11.
Griewank, Klaus, Henrike Westekemper, Rajmohan Murali, et al.. (2013). Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas. Clinical Cancer Research. 19(12). 3143–3152. 159 indexed citations
12.
Griewank, Klaus, Rajmohan Murali, Bastian Schilling, et al.. (2013). TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours. British Journal of Cancer. 109(2). 497–501. 91 indexed citations
13.
Westekemper, Henrike, Daniela Süßkind, Daniel Meller, et al.. (2010). Expression of MCSP and PRAME in conjunctival melanoma. British Journal of Ophthalmology. 94(10). 1322–1327. 25 indexed citations
14.
Süßkind, Daniela, et al.. (2010). Augenmanifestationen bei Xeroderma pigmentosum. Klinische Monatsblätter für Augenheilkunde. 228(3). 239–244. 1 indexed citations
15.
Westekemper, Henrike, Daniela Süßkind, Gerasimos Anastassiou, et al.. (2010). Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanoma. British Journal of Ophthalmology. 95(6). 853–858. 29 indexed citations
16.
Rohrbach, Jens Martin, et al.. (2009). Zur Situation der Ophthalmopathologie in Deutschland: eine aktuelle Bestandsaufnahme. Klinische Monatsblätter für Augenheilkunde. 226(9). 740–746. 4 indexed citations
17.
Rohrbach, Jens Martin, et al.. (2008). „Loses Auge“. Der Ophthalmologe. 106(6). 551–553. 1 indexed citations
18.
Buchgeister, Markus, Salvatore Grisanti, Daniela Süßkind, Michael Bamberg, & Frank Paulsen. (2007). A new fixation aid for the radiotherapy of eye tumors. Medical Physics. 34(12). 4649–4653. 7 indexed citations
19.
Voykov, Bogomil, Emmanuella Guenova, Daniela Süßkind, & Ulrich Schiefer. (2007). Tuberöse Sklerose: eine interdisziplinäre Diagnose. Klinische Monatsblätter für Augenheilkunde. 224(5). 441–444. 1 indexed citations
20.
Süßkind, Daniela & Jens Martin Rohrbach. (2007). Aderhautmelanom bei okulärer Melanozytose. Klinische Monatsblätter für Augenheilkunde. 224(3). 211–213. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zerrin Onadim Breakdown of academic impact, for papers by S Khorana Breakdown of academic impact, for papers by Barbro Werelius Breakdown of academic impact, for papers by Jennifer Richards‐Yutz Breakdown of academic impact, for papers by Jerry A. Shields Breakdown of academic impact, for papers by Irsan Kooi Breakdown of academic impact, for papers by Adriana C. H. van Engen–van Grunsven Breakdown of academic impact, for papers by Teemu Mäkitie Breakdown of academic impact, for papers by Amaury G. Dumont Breakdown of academic impact, for papers by Trinh Pham
Rankless by CCL
2026